nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Dacarbazine—pancreatic cancer	0.102	0.273	CbGbCtD
Fingolimod—CYP2E1—Tamoxifen—pancreatic cancer	0.0814	0.217	CbGbCtD
Fingolimod—CYP2D6—Tamoxifen—pancreatic cancer	0.0388	0.104	CbGbCtD
Fingolimod—S1PR1—umbilical vein—pancreatic cancer	0.0372	0.478	CbGeAlD
Fingolimod—CYP2D6—Erlotinib—pancreatic cancer	0.033	0.0881	CbGbCtD
Fingolimod—CYP3A4—Tamoxifen—pancreatic cancer	0.0247	0.0659	CbGbCtD
Fingolimod—CYP3A4—Erlotinib—pancreatic cancer	0.021	0.056	CbGbCtD
Fingolimod—CYP3A4—Irinotecan—pancreatic cancer	0.0189	0.0506	CbGbCtD
Fingolimod—CYP2D6—Doxorubicin—pancreatic cancer	0.0163	0.0435	CbGbCtD
Fingolimod—CYP3A4—Docetaxel—pancreatic cancer	0.0139	0.0371	CbGbCtD
Fingolimod—CYP3A4—Sunitinib—pancreatic cancer	0.0138	0.0369	CbGbCtD
Fingolimod—CYP3A4—Doxorubicin—pancreatic cancer	0.0103	0.0276	CbGbCtD
Fingolimod—SPHK1—islet of Langerhans—pancreatic cancer	0.00992	0.128	CbGeAlD
Fingolimod—S1PR3—pancreas—pancreatic cancer	0.008	0.103	CbGeAlD
Fingolimod—CYP4F2—digestive system—pancreatic cancer	0.0077	0.0991	CbGeAlD
Fingolimod—CYP4F12—pancreas—pancreatic cancer	0.0067	0.0862	CbGeAlD
Fingolimod—CYP4F12—digestive system—pancreatic cancer	0.00572	0.0736	CbGeAlD
Fingolimod—CYP2E1—digestive system—pancreatic cancer	0.000965	0.0124	CbGeAlD
Fingolimod—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.000896	0.00396	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.000874	0.00386	CcSEcCtD
Fingolimod—Mediastinal disorder—Erlotinib—pancreatic cancer	0.000871	0.00385	CcSEcCtD
Fingolimod—Alopecia—Tamoxifen—pancreatic cancer	0.000863	0.00381	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000856	0.00378	CcSEcCtD
Fingolimod—Alopecia—Erlotinib—pancreatic cancer	0.000854	0.00377	CcSEcCtD
Fingolimod—Bradycardia—Sunitinib—pancreatic cancer	0.000852	0.00376	CcSEcCtD
Fingolimod—Herpes zoster—Epirubicin—pancreatic cancer	0.00085	0.00375	CcSEcCtD
Fingolimod—Mental disorder—Erlotinib—pancreatic cancer	0.000847	0.00374	CcSEcCtD
Fingolimod—Influenza—Gemcitabine—pancreatic cancer	0.000839	0.0037	CcSEcCtD
Fingolimod—Back pain—Tamoxifen—pancreatic cancer	0.000822	0.00363	CcSEcCtD
Fingolimod—Connective tissue disorder—Sunitinib—pancreatic cancer	0.000822	0.00363	CcSEcCtD
Fingolimod—Back pain—Erlotinib—pancreatic cancer	0.000814	0.00359	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—pancreatic cancer	0.000786	0.00347	CcSEcCtD
Fingolimod—Eye disorder—Sunitinib—pancreatic cancer	0.000782	0.00345	CcSEcCtD
Fingolimod—Weight decreased—Irinotecan—pancreatic cancer	0.000779	0.00344	CcSEcCtD
Fingolimod—CYP3A4—digestive system—pancreatic cancer	0.000777	0.00999	CbGeAlD
Fingolimod—Cardiac disorder—Sunitinib—pancreatic cancer	0.000776	0.00343	CcSEcCtD
Fingolimod—Pneumonia—Irinotecan—pancreatic cancer	0.000772	0.00341	CcSEcCtD
Fingolimod—CYP2D6—digestive system—pancreatic cancer	0.000764	0.00983	CbGeAlD
Fingolimod—Leukopenia—Tamoxifen—pancreatic cancer	0.000761	0.00336	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—pancreatic cancer	0.00076	0.00336	CcSEcCtD
Fingolimod—Angiopathy—Sunitinib—pancreatic cancer	0.000759	0.00335	CcSEcCtD
Fingolimod—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000754	0.00333	CcSEcCtD
Fingolimod—Pneumonia—Gemcitabine—pancreatic cancer	0.000752	0.00332	CcSEcCtD
Fingolimod—Cough—Tamoxifen—pancreatic cancer	0.000742	0.00328	CcSEcCtD
Fingolimod—Pneumonia—Fluorouracil—pancreatic cancer	0.000739	0.00327	CcSEcCtD
Fingolimod—Alopecia—Sunitinib—pancreatic cancer	0.000739	0.00327	CcSEcCtD
Fingolimod—Infestation—Fluorouracil—pancreatic cancer	0.000735	0.00325	CcSEcCtD
Fingolimod—Infestation NOS—Fluorouracil—pancreatic cancer	0.000735	0.00325	CcSEcCtD
Fingolimod—Hypertension—Tamoxifen—pancreatic cancer	0.000734	0.00324	CcSEcCtD
Fingolimod—Cough—Erlotinib—pancreatic cancer	0.000734	0.00324	CcSEcCtD
Fingolimod—Mental disorder—Sunitinib—pancreatic cancer	0.000733	0.00324	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000711	0.00314	CcSEcCtD
Fingolimod—Back pain—Sunitinib—pancreatic cancer	0.000704	0.00311	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—pancreatic cancer	0.000703	0.00311	CcSEcCtD
Fingolimod—Bradycardia—Irinotecan—pancreatic cancer	0.000701	0.0031	CcSEcCtD
Fingolimod—Sinusitis—Fluorouracil—pancreatic cancer	0.00069	0.00305	CcSEcCtD
Fingolimod—Infection—Tamoxifen—pancreatic cancer	0.000689	0.00305	CcSEcCtD
Fingolimod—Infection—Erlotinib—pancreatic cancer	0.000682	0.00301	CcSEcCtD
Fingolimod—Migraine—Docetaxel—pancreatic cancer	0.000678	0.00299	CcSEcCtD
Fingolimod—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000677	0.00299	CcSEcCtD
Fingolimod—Nervous system disorder—Erlotinib—pancreatic cancer	0.000673	0.00297	CcSEcCtD
Fingolimod—Skin disorder—Erlotinib—pancreatic cancer	0.000667	0.00295	CcSEcCtD
Fingolimod—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.00066	0.00291	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—pancreatic cancer	0.00066	0.00291	CcSEcCtD
Fingolimod—Leukopenia—Sunitinib—pancreatic cancer	0.000652	0.00288	CcSEcCtD
Fingolimod—Cardiac disorder—Irinotecan—pancreatic cancer	0.000639	0.00283	CcSEcCtD
Fingolimod—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000636	0.00281	CcSEcCtD
Fingolimod—Cough—Sunitinib—pancreatic cancer	0.000635	0.00281	CcSEcCtD
Fingolimod—Hypertension—Sunitinib—pancreatic cancer	0.000629	0.00278	CcSEcCtD
Fingolimod—Angiopathy—Irinotecan—pancreatic cancer	0.000625	0.00276	CcSEcCtD
Fingolimod—Paraesthesia—Tamoxifen—pancreatic cancer	0.000623	0.00275	CcSEcCtD
Fingolimod—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000623	0.00275	CcSEcCtD
Fingolimod—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000621	0.00274	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.00062	0.00274	CcSEcCtD
Fingolimod—Dyspnoea—Tamoxifen—pancreatic cancer	0.000619	0.00273	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000616	0.00272	CcSEcCtD
Fingolimod—Dyspnoea—Erlotinib—pancreatic cancer	0.000612	0.0027	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—pancreatic cancer	0.00061	0.0027	CcSEcCtD
Fingolimod—Angiopathy—Gemcitabine—pancreatic cancer	0.000609	0.00269	CcSEcCtD
Fingolimod—Alopecia—Irinotecan—pancreatic cancer	0.000609	0.00269	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000607	0.00268	CcSEcCtD
Fingolimod—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000605	0.00267	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000599	0.00265	CcSEcCtD
Fingolimod—Fatigue—Tamoxifen—pancreatic cancer	0.000598	0.00264	CcSEcCtD
Fingolimod—Alopecia—Gemcitabine—pancreatic cancer	0.000593	0.00262	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000593	0.00262	CcSEcCtD
Fingolimod—Fatigue—Erlotinib—pancreatic cancer	0.000592	0.00261	CcSEcCtD
Fingolimod—Infection—Sunitinib—pancreatic cancer	0.00059	0.00261	CcSEcCtD
Fingolimod—Alopecia—Fluorouracil—pancreatic cancer	0.000583	0.00258	CcSEcCtD
Fingolimod—Nervous system disorder—Sunitinib—pancreatic cancer	0.000583	0.00257	CcSEcCtD
Fingolimod—Back pain—Irinotecan—pancreatic cancer	0.00058	0.00256	CcSEcCtD
Fingolimod—Skin disorder—Sunitinib—pancreatic cancer	0.000577	0.00255	CcSEcCtD
Fingolimod—Back pain—Gemcitabine—pancreatic cancer	0.000565	0.0025	CcSEcCtD
Fingolimod—Vision blurred—Fluorouracil—pancreatic cancer	0.000541	0.00239	CcSEcCtD
Fingolimod—Weight decreased—Docetaxel—pancreatic cancer	0.000538	0.00238	CcSEcCtD
Fingolimod—Leukopenia—Irinotecan—pancreatic cancer	0.000537	0.00237	CcSEcCtD
Fingolimod—Pneumonia—Docetaxel—pancreatic cancer	0.000534	0.00236	CcSEcCtD
Fingolimod—Paraesthesia—Sunitinib—pancreatic cancer	0.000534	0.00236	CcSEcCtD
Fingolimod—Infestation NOS—Docetaxel—pancreatic cancer	0.000531	0.00234	CcSEcCtD
Fingolimod—Infestation—Docetaxel—pancreatic cancer	0.000531	0.00234	CcSEcCtD
Fingolimod—Dyspnoea—Sunitinib—pancreatic cancer	0.00053	0.00234	CcSEcCtD
Fingolimod—Cough—Irinotecan—pancreatic cancer	0.000523	0.00231	CcSEcCtD
Fingolimod—Leukopenia—Gemcitabine—pancreatic cancer	0.000523	0.00231	CcSEcCtD
Fingolimod—Hypertension—Irinotecan—pancreatic cancer	0.000518	0.00229	CcSEcCtD
Fingolimod—Eczema—Epirubicin—pancreatic cancer	0.000517	0.00228	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—pancreatic cancer	0.000514	0.00227	CcSEcCtD
Fingolimod—Leukopenia—Fluorouracil—pancreatic cancer	0.000514	0.00227	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000513	0.00227	CcSEcCtD
Fingolimod—Fatigue—Sunitinib—pancreatic cancer	0.000512	0.00226	CcSEcCtD
Fingolimod—Cough—Gemcitabine—pancreatic cancer	0.00051	0.00225	CcSEcCtD
Fingolimod—Hypertension—Gemcitabine—pancreatic cancer	0.000504	0.00223	CcSEcCtD
Fingolimod—Asthenia—Tamoxifen—pancreatic cancer	0.000498	0.0022	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000494	0.00218	CcSEcCtD
Fingolimod—Asthenia—Erlotinib—pancreatic cancer	0.000493	0.00218	CcSEcCtD
Fingolimod—Pruritus—Tamoxifen—pancreatic cancer	0.000491	0.00217	CcSEcCtD
Fingolimod—Infection—Irinotecan—pancreatic cancer	0.000486	0.00215	CcSEcCtD
Fingolimod—Pruritus—Erlotinib—pancreatic cancer	0.000486	0.00215	CcSEcCtD
Fingolimod—Nervous system disorder—Irinotecan—pancreatic cancer	0.00048	0.00212	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—pancreatic cancer	0.000478	0.00211	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—pancreatic cancer	0.000476	0.0021	CcSEcCtD
Fingolimod—Diarrhoea—Tamoxifen—pancreatic cancer	0.000475	0.0021	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000474	0.00209	CcSEcCtD
Fingolimod—Infection—Gemcitabine—pancreatic cancer	0.000474	0.00209	CcSEcCtD
Fingolimod—Diarrhoea—Erlotinib—pancreatic cancer	0.00047	0.00208	CcSEcCtD
Fingolimod—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000468	0.00207	CcSEcCtD
Fingolimod—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000468	0.00207	CcSEcCtD
Fingolimod—Infection—Fluorouracil—pancreatic cancer	0.000466	0.00206	CcSEcCtD
Fingolimod—Skin disorder—Gemcitabine—pancreatic cancer	0.000463	0.00205	CcSEcCtD
Fingolimod—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00046	0.00203	CcSEcCtD
Fingolimod—Dizziness—Tamoxifen—pancreatic cancer	0.000459	0.00203	CcSEcCtD
Fingolimod—Hypotension—Irinotecan—pancreatic cancer	0.000457	0.00202	CcSEcCtD
Fingolimod—Migraine—Epirubicin—pancreatic cancer	0.000457	0.00202	CcSEcCtD
Fingolimod—Dizziness—Erlotinib—pancreatic cancer	0.000454	0.00201	CcSEcCtD
Fingolimod—Hypotension—Gemcitabine—pancreatic cancer	0.000446	0.00197	CcSEcCtD
Fingolimod—Eye disorder—Docetaxel—pancreatic cancer	0.000445	0.00197	CcSEcCtD
Fingolimod—Cardiac disorder—Docetaxel—pancreatic cancer	0.000442	0.00195	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—pancreatic cancer	0.000442	0.00195	CcSEcCtD
Fingolimod—Paraesthesia—Irinotecan—pancreatic cancer	0.00044	0.00194	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000439	0.00194	CcSEcCtD
Fingolimod—Hypotension—Fluorouracil—pancreatic cancer	0.000438	0.00194	CcSEcCtD
Fingolimod—Dyspnoea—Irinotecan—pancreatic cancer	0.000436	0.00193	CcSEcCtD
Fingolimod—Headache—Tamoxifen—pancreatic cancer	0.000435	0.00192	CcSEcCtD
Fingolimod—Angiopathy—Docetaxel—pancreatic cancer	0.000432	0.00191	CcSEcCtD
Fingolimod—Headache—Erlotinib—pancreatic cancer	0.00043	0.0019	CcSEcCtD
Fingolimod—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000429	0.0019	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000429	0.00189	CcSEcCtD
Fingolimod—Paraesthesia—Gemcitabine—pancreatic cancer	0.000428	0.00189	CcSEcCtD
Fingolimod—Asthenia—Sunitinib—pancreatic cancer	0.000426	0.00188	CcSEcCtD
Fingolimod—Dyspnoea—Gemcitabine—pancreatic cancer	0.000425	0.00188	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—pancreatic cancer	0.000423	0.00187	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000423	0.00187	CcSEcCtD
Fingolimod—Fatigue—Irinotecan—pancreatic cancer	0.000422	0.00186	CcSEcCtD
Fingolimod—Paraesthesia—Fluorouracil—pancreatic cancer	0.000421	0.00186	CcSEcCtD
Fingolimod—Alopecia—Docetaxel—pancreatic cancer	0.000421	0.00186	CcSEcCtD
Fingolimod—Pruritus—Sunitinib—pancreatic cancer	0.00042	0.00186	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000418	0.00185	CcSEcCtD
Fingolimod—Dyspnoea—Fluorouracil—pancreatic cancer	0.000418	0.00185	CcSEcCtD
Fingolimod—Mental disorder—Docetaxel—pancreatic cancer	0.000417	0.00184	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000412	0.00182	CcSEcCtD
Fingolimod—Fatigue—Gemcitabine—pancreatic cancer	0.000411	0.00182	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00041	0.00181	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000409	0.00181	CcSEcCtD
Fingolimod—Diarrhoea—Sunitinib—pancreatic cancer	0.000407	0.0018	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000405	0.00179	CcSEcCtD
Fingolimod—Influenza—Epirubicin—pancreatic cancer	0.000401	0.00177	CcSEcCtD
Fingolimod—Back pain—Docetaxel—pancreatic cancer	0.000401	0.00177	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000397	0.00175	CcSEcCtD
Fingolimod—Dizziness—Sunitinib—pancreatic cancer	0.000393	0.00174	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000387	0.00171	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—pancreatic cancer	0.000386	0.00171	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000379	0.00167	CcSEcCtD
Fingolimod—Headache—Sunitinib—pancreatic cancer	0.000372	0.00164	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—pancreatic cancer	0.000371	0.00164	CcSEcCtD
Fingolimod—Leukopenia—Docetaxel—pancreatic cancer	0.000371	0.00164	CcSEcCtD
Fingolimod—Palpitations—Docetaxel—pancreatic cancer	0.000366	0.00162	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—pancreatic cancer	0.000363	0.0016	CcSEcCtD
Fingolimod—Cough—Docetaxel—pancreatic cancer	0.000362	0.0016	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—pancreatic cancer	0.00036	0.00159	CcSEcCtD
Fingolimod—Hypertension—Docetaxel—pancreatic cancer	0.000358	0.00158	CcSEcCtD
Fingolimod—Infestation—Epirubicin—pancreatic cancer	0.000358	0.00158	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—pancreatic cancer	0.000358	0.00158	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—pancreatic cancer	0.000357	0.00158	CcSEcCtD
Fingolimod—Asthenia—Irinotecan—pancreatic cancer	0.000351	0.00155	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000351	0.00155	CcSEcCtD
Fingolimod—Asthenia—Gemcitabine—pancreatic cancer	0.000342	0.00151	CcSEcCtD
Fingolimod—Pruritus—Gemcitabine—pancreatic cancer	0.000337	0.00149	CcSEcCtD
Fingolimod—Infection—Docetaxel—pancreatic cancer	0.000336	0.00149	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—pancreatic cancer	0.000336	0.00148	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—pancreatic cancer	0.000336	0.00148	CcSEcCtD
Fingolimod—Diarrhoea—Irinotecan—pancreatic cancer	0.000335	0.00148	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—pancreatic cancer	0.000333	0.00147	CcSEcCtD
Fingolimod—Nervous system disorder—Docetaxel—pancreatic cancer	0.000332	0.00147	CcSEcCtD
Fingolimod—Pruritus—Fluorouracil—pancreatic cancer	0.000332	0.00147	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—pancreatic cancer	0.000331	0.00146	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—pancreatic cancer	0.000331	0.00146	CcSEcCtD
Fingolimod—Skin disorder—Docetaxel—pancreatic cancer	0.000329	0.00145	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—pancreatic cancer	0.000327	0.00145	CcSEcCtD
Fingolimod—Diarrhoea—Gemcitabine—pancreatic cancer	0.000326	0.00144	CcSEcCtD
Fingolimod—Dizziness—Irinotecan—pancreatic cancer	0.000324	0.00143	CcSEcCtD
Fingolimod—Diarrhoea—Fluorouracil—pancreatic cancer	0.000321	0.00142	CcSEcCtD
Fingolimod—Hypotension—Docetaxel—pancreatic cancer	0.000316	0.0014	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000316	0.00139	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—pancreatic cancer	0.000311	0.00137	CcSEcCtD
Fingolimod—Dizziness—Fluorouracil—pancreatic cancer	0.00031	0.00137	CcSEcCtD
Fingolimod—Headache—Irinotecan—pancreatic cancer	0.000307	0.00135	CcSEcCtD
Fingolimod—Paraesthesia—Docetaxel—pancreatic cancer	0.000304	0.00134	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—pancreatic cancer	0.000303	0.00134	CcSEcCtD
Fingolimod—Dyspnoea—Docetaxel—pancreatic cancer	0.000302	0.00133	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—pancreatic cancer	0.0003	0.00133	CcSEcCtD
Fingolimod—Headache—Gemcitabine—pancreatic cancer	0.000299	0.00132	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—pancreatic cancer	0.000298	0.00132	CcSEcCtD
Fingolimod—Headache—Fluorouracil—pancreatic cancer	0.000294	0.0013	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000292	0.00129	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000292	0.00129	CcSEcCtD
Fingolimod—Fatigue—Docetaxel—pancreatic cancer	0.000292	0.00129	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—pancreatic cancer	0.000291	0.00129	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00029	0.00128	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—pancreatic cancer	0.000284	0.00125	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—pancreatic cancer	0.000281	0.00124	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—pancreatic cancer	0.000278	0.00123	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000276	0.00122	CcSEcCtD
Fingolimod—Back pain—Epirubicin—pancreatic cancer	0.000271	0.0012	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—pancreatic cancer	0.00027	0.00119	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000268	0.00118	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—pancreatic cancer	0.000264	0.00116	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—pancreatic cancer	0.000263	0.00116	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—pancreatic cancer	0.00026	0.00115	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—pancreatic cancer	0.00025	0.00111	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—pancreatic cancer	0.00025	0.00111	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—pancreatic cancer	0.000247	0.00109	CcSEcCtD
Fingolimod—Cough—Epirubicin—pancreatic cancer	0.000244	0.00108	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—pancreatic cancer	0.000244	0.00108	CcSEcCtD
Fingolimod—Asthenia—Docetaxel—pancreatic cancer	0.000243	0.00107	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—pancreatic cancer	0.000241	0.00107	CcSEcCtD
Fingolimod—Pruritus—Docetaxel—pancreatic cancer	0.000239	0.00106	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000236	0.00104	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—pancreatic cancer	0.000232	0.00102	CcSEcCtD
Fingolimod—Diarrhoea—Docetaxel—pancreatic cancer	0.000232	0.00102	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—pancreatic cancer	0.000229	0.00101	CcSEcCtD
Fingolimod—Infection—Epirubicin—pancreatic cancer	0.000227	0.001	CcSEcCtD
Fingolimod—Cough—Doxorubicin—pancreatic cancer	0.000226	0.000998	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—pancreatic cancer	0.000224	0.000989	CcSEcCtD
Fingolimod—Dizziness—Docetaxel—pancreatic cancer	0.000224	0.000989	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—pancreatic cancer	0.000223	0.000987	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—pancreatic cancer	0.000222	0.00098	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000219	0.000967	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—pancreatic cancer	0.000213	0.000942	CcSEcCtD
Fingolimod—Headache—Docetaxel—pancreatic cancer	0.000212	0.000937	CcSEcCtD
Fingolimod—Infection—Doxorubicin—pancreatic cancer	0.00021	0.000927	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000207	0.000915	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—pancreatic cancer	0.000205	0.000906	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—pancreatic cancer	0.000205	0.000906	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—pancreatic cancer	0.000203	0.000899	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—pancreatic cancer	0.000197	0.000872	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000197	0.000871	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—pancreatic cancer	0.000197	0.000869	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—pancreatic cancer	0.00019	0.000838	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—pancreatic cancer	0.000188	0.000832	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000182	0.000806	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—pancreatic cancer	0.000182	0.000804	CcSEcCtD
Fingolimod—Asthenia—Epirubicin—pancreatic cancer	0.000164	0.000724	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—pancreatic cancer	0.000161	0.000713	CcSEcCtD
Fingolimod—Diarrhoea—Epirubicin—pancreatic cancer	0.000156	0.00069	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—pancreatic cancer	0.000152	0.000669	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—pancreatic cancer	0.000151	0.000667	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—pancreatic cancer	0.000149	0.00066	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—pancreatic cancer	0.000145	0.000638	CcSEcCtD
Fingolimod—Headache—Epirubicin—pancreatic cancer	0.000143	0.000632	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—pancreatic cancer	0.00014	0.000617	CcSEcCtD
Fingolimod—Headache—Doxorubicin—pancreatic cancer	0.000132	0.000585	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—pancreatic cancer	8.16e-05	0.000254	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KDR—pancreatic cancer	8.13e-05	0.000253	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CG—pancreatic cancer	8.06e-05	0.000251	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SMAD4—pancreatic cancer	8.03e-05	0.00025	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—APOE—pancreatic cancer	7.98e-05	0.000248	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—APOE—pancreatic cancer	7.98e-05	0.000248	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HES1—pancreatic cancer	7.84e-05	0.000244	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KDR—pancreatic cancer	7.82e-05	0.000243	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KDR—pancreatic cancer	7.82e-05	0.000243	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PPARG—pancreatic cancer	7.78e-05	0.000242	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TERT—pancreatic cancer	7.77e-05	0.000241	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NFKBIA—pancreatic cancer	7.73e-05	0.00024	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—APOE—pancreatic cancer	7.67e-05	0.000239	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NOTCH1—pancreatic cancer	7.65e-05	0.000238	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CG—pancreatic cancer	7.49e-05	0.000233	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—NRAS—pancreatic cancer	7.49e-05	0.000233	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NFKBIA—pancreatic cancer	7.44e-05	0.000231	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NFKBIA—pancreatic cancer	7.44e-05	0.000231	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HIF1A—pancreatic cancer	7.43e-05	0.000231	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TSC2—pancreatic cancer	7.41e-05	0.00023	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGF—pancreatic cancer	7.4e-05	0.00023	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NOTCH1—pancreatic cancer	7.37e-05	0.000229	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NOTCH1—pancreatic cancer	7.37e-05	0.000229	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.26e-05	0.000226	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APOE—pancreatic cancer	7.25e-05	0.000225	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CG—pancreatic cancer	7.21e-05	0.000224	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CG—pancreatic cancer	7.21e-05	0.000224	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NRAS—pancreatic cancer	7.21e-05	0.000224	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—NRAS—pancreatic cancer	7.21e-05	0.000224	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CB—pancreatic cancer	7.15e-05	0.000222	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGF—pancreatic cancer	7.12e-05	0.000221	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGF—pancreatic cancer	7.12e-05	0.000221	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KDR—pancreatic cancer	7.1e-05	0.000221	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—pancreatic cancer	7.09e-05	0.00022	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CD—pancreatic cancer	7.09e-05	0.00022	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CG—pancreatic cancer	6.93e-05	0.000215	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TERT—pancreatic cancer	6.87e-05	0.000214	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—pancreatic cancer	6.82e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NFKBIA—pancreatic cancer	6.76e-05	0.00021	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOTCH1—pancreatic cancer	6.69e-05	0.000208	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARG—pancreatic cancer	6.68e-05	0.000208	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CD—pancreatic cancer	6.58e-05	0.000205	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HIF1A—pancreatic cancer	6.57e-05	0.000204	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—pancreatic cancer	6.56e-05	0.000204	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—pancreatic cancer	6.56e-05	0.000204	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TSC2—pancreatic cancer	6.56e-05	0.000204	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CG—pancreatic cancer	6.54e-05	0.000203	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NRAS—pancreatic cancer	6.54e-05	0.000203	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.52e-05	0.000203	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGF—pancreatic cancer	6.47e-05	0.000201	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—pancreatic cancer	6.44e-05	0.0002	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APOE—pancreatic cancer	6.42e-05	0.000199	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CD—pancreatic cancer	6.33e-05	0.000197	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CD—pancreatic cancer	6.33e-05	0.000197	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KDR—pancreatic cancer	6.29e-05	0.000195	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.27e-05	0.000195	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.27e-05	0.000195	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—pancreatic cancer	6.2e-05	0.000193	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—pancreatic cancer	6.2e-05	0.000193	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTEN—pancreatic cancer	6.18e-05	0.000192	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CB—pancreatic cancer	6.18e-05	0.000192	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—pancreatic cancer	6.12e-05	0.00019	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CD—pancreatic cancer	6.09e-05	0.000189	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NFKBIA—pancreatic cancer	5.98e-05	0.000186	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—pancreatic cancer	5.96e-05	0.000185	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOTCH1—pancreatic cancer	5.92e-05	0.000184	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PIK3CA—pancreatic cancer	5.92e-05	0.000184	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CG—pancreatic cancer	5.79e-05	0.00018	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CD—pancreatic cancer	5.75e-05	0.000179	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CB—pancreatic cancer	5.74e-05	0.000178	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGF—pancreatic cancer	5.72e-05	0.000178	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CA—pancreatic cancer	5.7e-05	0.000177	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CA—pancreatic cancer	5.7e-05	0.000177	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.7e-05	0.000177	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—pancreatic cancer	5.63e-05	0.000175	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CB—pancreatic cancer	5.52e-05	0.000172	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CB—pancreatic cancer	5.52e-05	0.000172	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—pancreatic cancer	5.51e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—pancreatic cancer	5.48e-05	0.00017	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTEN—pancreatic cancer	5.34e-05	0.000166	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—pancreatic cancer	5.32e-05	0.000166	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CB—pancreatic cancer	5.31e-05	0.000165	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—pancreatic cancer	5.31e-05	0.000165	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—pancreatic cancer	5.31e-05	0.000165	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—pancreatic cancer	5.28e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—pancreatic cancer	5.27e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—pancreatic cancer	5.27e-05	0.000164	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—pancreatic cancer	5.26e-05	0.000163	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.17e-05	0.000161	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—pancreatic cancer	5.14e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—pancreatic cancer	5.13e-05	0.000159	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—pancreatic cancer	5.13e-05	0.000159	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CD—pancreatic cancer	5.09e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—pancreatic cancer	5.09e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—pancreatic cancer	5.08e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—pancreatic cancer	5.08e-05	0.000158	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CB—pancreatic cancer	5.01e-05	0.000156	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—pancreatic cancer	4.99e-05	0.000155	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTEN—pancreatic cancer	4.96e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—pancreatic cancer	4.94e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—pancreatic cancer	4.94e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—pancreatic cancer	4.89e-05	0.000152	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—pancreatic cancer	4.89e-05	0.000152	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—pancreatic cancer	4.84e-05	0.00015	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—pancreatic cancer	4.82e-05	0.00015	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—pancreatic cancer	4.8e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—pancreatic cancer	4.8e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—pancreatic cancer	4.79e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTEN—pancreatic cancer	4.77e-05	0.000148	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTEN—pancreatic cancer	4.77e-05	0.000148	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—pancreatic cancer	4.65e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—pancreatic cancer	4.65e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—pancreatic cancer	4.65e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—pancreatic cancer	4.61e-05	0.000143	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SRC—pancreatic cancer	4.6e-05	0.000143	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTEN—pancreatic cancer	4.59e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PRSS1—pancreatic cancer	4.52e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—pancreatic cancer	4.49e-05	0.00014	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—pancreatic cancer	4.48e-05	0.000139	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—pancreatic cancer	4.44e-05	0.000138	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CB—pancreatic cancer	4.44e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—pancreatic cancer	4.43e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SRC—pancreatic cancer	4.42e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SRC—pancreatic cancer	4.42e-05	0.000138	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—pancreatic cancer	4.42e-05	0.000137	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—pancreatic cancer	4.36e-05	0.000136	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—pancreatic cancer	4.36e-05	0.000135	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—pancreatic cancer	4.33e-05	0.000135	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—pancreatic cancer	4.31e-05	0.000134	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—pancreatic cancer	4.31e-05	0.000134	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—pancreatic cancer	4.27e-05	0.000133	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—pancreatic cancer	4.27e-05	0.000133	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—pancreatic cancer	4.26e-05	0.000133	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—pancreatic cancer	4.26e-05	0.000132	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—pancreatic cancer	4.26e-05	0.000132	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—pancreatic cancer	4.23e-05	0.000131	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—pancreatic cancer	4.12e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TGFB1—pancreatic cancer	4.11e-05	0.000128	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—pancreatic cancer	4.08e-05	0.000127	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—pancreatic cancer	4.03e-05	0.000125	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SRC—pancreatic cancer	4.02e-05	0.000125	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—pancreatic cancer	3.97e-05	0.000123	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—pancreatic cancer	3.96e-05	0.000123	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—pancreatic cancer	3.96e-05	0.000123	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TGFB1—pancreatic cancer	3.96e-05	0.000123	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TGFB1—pancreatic cancer	3.96e-05	0.000123	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—pancreatic cancer	3.93e-05	0.000122	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ARG2—pancreatic cancer	3.92e-05	0.000122	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—pancreatic cancer	3.91e-05	0.000122	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—pancreatic cancer	3.88e-05	0.000121	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—pancreatic cancer	3.88e-05	0.000121	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—pancreatic cancer	3.87e-05	0.00012	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—pancreatic cancer	3.87e-05	0.00012	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—pancreatic cancer	3.86e-05	0.00012	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—pancreatic cancer	3.83e-05	0.000119	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—pancreatic cancer	3.81e-05	0.000118	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—pancreatic cancer	3.77e-05	0.000117	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—pancreatic cancer	3.66e-05	0.000114	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—pancreatic cancer	3.66e-05	0.000114	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—pancreatic cancer	3.6e-05	0.000112	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TGFB1—pancreatic cancer	3.59e-05	0.000112	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—pancreatic cancer	3.56e-05	0.000111	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SRC—pancreatic cancer	3.56e-05	0.000111	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—pancreatic cancer	3.52e-05	0.000109	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—pancreatic cancer	3.5e-05	0.000109	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—pancreatic cancer	3.46e-05	0.000108	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—pancreatic cancer	3.43e-05	0.000107	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMP—pancreatic cancer	3.43e-05	0.000107	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—pancreatic cancer	3.42e-05	0.000106	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—pancreatic cancer	3.38e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—pancreatic cancer	3.37e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—pancreatic cancer	3.37e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—pancreatic cancer	3.33e-05	0.000103	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—pancreatic cancer	3.26e-05	0.000101	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—pancreatic cancer	3.26e-05	0.000101	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—pancreatic cancer	3.23e-05	0.000101	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—pancreatic cancer	3.23e-05	0.000101	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.21e-05	9.98e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—pancreatic cancer	3.19e-05	9.9e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—pancreatic cancer	3.18e-05	9.88e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—pancreatic cancer	3.12e-05	9.69e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—pancreatic cancer	3.11e-05	9.68e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—pancreatic cancer	3.11e-05	9.68e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—pancreatic cancer	3.08e-05	9.56e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—pancreatic cancer	3.06e-05	9.5e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—pancreatic cancer	2.96e-05	9.19e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—pancreatic cancer	2.94e-05	9.15e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—pancreatic cancer	2.86e-05	8.88e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—pancreatic cancer	2.83e-05	8.79e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.78e-05	8.65e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GLP1R—pancreatic cancer	2.76e-05	8.59e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—pancreatic cancer	2.75e-05	8.55e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—pancreatic cancer	2.75e-05	8.55e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DPYD—pancreatic cancer	2.72e-05	8.45e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—pancreatic cancer	2.7e-05	8.41e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—pancreatic cancer	2.64e-05	8.21e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—pancreatic cancer	2.62e-05	8.13e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	2.58e-05	8.02e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—pancreatic cancer	2.5e-05	7.78e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—pancreatic cancer	2.5e-05	7.76e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.43e-05	7.56e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—pancreatic cancer	2.21e-05	6.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.1e-05	6.52e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CD44—pancreatic cancer	2e-05	6.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.96e-05	6.09e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.93e-05	6e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GCG—pancreatic cancer	1.92e-05	5.95e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.83e-05	5.69e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.82e-05	5.66e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—STK11—pancreatic cancer	1.8e-05	5.6e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.59e-05	4.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—pancreatic cancer	1.55e-05	4.81e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CD44—pancreatic cancer	1.42e-05	4.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GCG—pancreatic cancer	1.36e-05	4.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.28e-05	3.98e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—STK11—pancreatic cancer	1.28e-05	3.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.26e-05	3.92e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOE—pancreatic cancer	1.26e-05	3.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.2e-05	3.72e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	1.14e-05	3.53e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.1e-05	3.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—pancreatic cancer	1.1e-05	3.41e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	9.99e-06	3.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CD44—pancreatic cancer	9.27e-06	2.88e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOE—pancreatic cancer	8.94e-06	2.78e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GCG—pancreatic cancer	8.89e-06	2.76e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	8.71e-06	2.71e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—pancreatic cancer	8.63e-06	2.68e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—STK11—pancreatic cancer	8.35e-06	2.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.07e-06	2.51e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—pancreatic cancer	7.79e-06	2.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—pancreatic cancer	7.53e-06	2.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.19e-06	2.23e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.09e-06	2.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.18e-06	1.92e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.12e-06	1.9e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOE—pancreatic cancer	5.84e-06	1.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.34e-06	1.66e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	5.31e-06	1.65e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.27e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.09e-06	1.58e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.64e-06	1.44e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—pancreatic cancer	4.34e-06	1.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.04e-06	1.26e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4e-06	1.24e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.77e-06	1.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.49e-06	1.09e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.08e-06	9.57e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.46e-06	7.66e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.01e-06	6.26e-06	CbGpPWpGaD
